|
Market Closed -
NYSE
00:00:03 31/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 146.00 USD | -0.36% |
|
-1.00% | +1.37% |
| 10-30 | Citigroup Adjusts Price Target on D.R. Horton to $152 From $150 | MT |
| 10-30 | UBS Adjusts Price Target on D.R. Horton to $186 From $206, Keeps Buy Rating | MT |
Company Valuation: DR Horton
Data adjusted to current consolidation scope
| Fiscal Period: September | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 30,078 | 23,403 | 36,357 | 62,160 | 50,523 | 39,630 | - | - |
| Change | - | -22.19% | 55.35% | 70.97% | -18.72% | -21.56% | - | - |
| Enterprise Value (EV) 1 | 32,280 | 26,929 | 37,578 | 63,562 | 53,503 | 42,215 | 43,591 | 43,625 |
| Change | - | -16.57% | 39.54% | 69.15% | -15.82% | -21.1% | 2.64% | 0.08% |
| P/E | 7.36x | 4.08x | 7.78x | 13.3x | 14.6x | 13.5x | 15x | 12x |
| PBR | 2.01x | 1.19x | 1.59x | 2.44x | 2.06x | 1.61x | 1.69x | 1.56x |
| PEG | - | 0.1x | -0.5x | 3.53x | -0.8x | -1.1x | -2.28x | 0.5x |
| Capitalization / Revenue | 1.08x | 0.7x | 1.03x | 1.69x | 1.48x | 1.16x | 1.22x | 1.15x |
| EV / Revenue | 1.16x | 0.8x | 1.06x | 1.73x | 1.56x | 1.28x | 1.35x | 1.26x |
| EV / EBITDA | 6.19x | 3.71x | 6.85x | 11.3x | 12.4x | 11.5x | 9.84x | 8.59x |
| EV / EBIT | 6.72x | 3.89x | 7.24x | 11.9x | 13.3x | 12.5x | 13.5x | 11.4x |
| EV / FCF | 121x | 65.1x | 9.04x | 31.4x | 16.3x | 12.6x | 16.2x | - |
| FCF Yield | 0.83% | 1.54% | 11.1% | 3.19% | 6.14% | 7.93% | 6.17% | - |
| Dividend per Share 2 | 0.8 | 0.925 | 1.025 | 1.2 | 1.6 | 1.792 | 1.99 | 2.103 |
| Rate of return | 0.95% | 1.37% | 0.95% | 0.63% | 0.94% | 1.23% | 1.36% | 1.44% |
| EPS 2 | 11.41 | 16.51 | 13.82 | 14.34 | 11.57 | 10.11 | 9.739 | 12.12 |
| Distribution rate | 7.01% | 5.6% | 7.42% | 8.37% | 13.8% | 17.2% | 20.4% | 17.4% |
| Net sales 1 | 27,774 | 33,480 | 35,460 | 36,801 | 34,250 | 33,043 | 32,355 | 34,541 |
| EBITDA 1 | 5,212 | 7,253 | 5,486 | 5,645 | 4,324 | 3,668 | 4,428 | 5,077 |
| EBIT 1 | 4,802 | 6,924 | 5,188 | 5,348 | 4,033 | 3,374 | 3,219 | 3,830 |
| Net income 1 | 4,176 | 5,858 | 4,746 | 4,756 | 3,585 | 2,889 | 2,581 | 3,052 |
| Net Debt 1 | 2,202 | 3,526 | 1,221 | 1,401 | 2,980 | 3,994 | 3,962 | 3,995 |
| Reference price 2 | 83.97 | 67.35 | 107.47 | 190.77 | 169.47 | 146.00 | 146.00 | 146.00 |
| Nbr of stocks (in thousands) | 358,194 | 347,481 | 338,297 | 325,839 | 298,124 | 271,436 | - | - |
| Announcement Date | 09/11/21 | 09/11/22 | 07/11/23 | 29/10/24 | 28/10/25 | 29/10/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 14x | 1.3x | 10.01x | 1.23% | 39.63B | |
| 13.39x | 1.49x | 9.02x | 0.83% | 22.96B | |
| 17.91x | 0.77x | 11.99x | 2.3% | 20.65B | |
| 10.23x | 0.94x | 8.88x | 3.9% | 17.95B | |
| 17.61x | 1.72x | 11.8x | -.--% | 15.76B | |
| 10.01x | 0.83x | 8.92x | 4.16% | 14.33B | |
| 11.48x | 1.37x | 8.3x | 0.7% | 13.45B | |
| 13.18x | 0.81x | 6.51x | 3.19% | 6.6B | |
| 14.74x | 0.65x | 7.88x | 0.31% | 6.03B | |
| Average | 13.62x | 1.10x | 9.26x | 1.85% | 17.49B | |
| Weighted average by Cap. | 13.77x | 1.17x | 9.70x | 1.76% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DHI Stock
- Valuation DR Horton
Select your edition
All financial news and data tailored to specific country editions
